Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2021

Jul 12, 2021

59231_rns_2021-07-12_ce254211-e396-4150-abef-5776ca8607fc.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

9[th] July, 2021

==> picture [167 x 46] intentionally omitted <==

National Stock Exchange of India Limited

Listing Department Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

NSE Symbol – WOCKPHARMA

Dear Sir/ Madam,

This is with reference to your communication dated 5[th] July, 2021, advising us to provide clarification with respect to our intimation dated 3[rd] July, 2021, regarding 'Incorporation of a subsidiary of Wockhardt Limited ( the Company ) - Wockhardt Biologics Limited’

In view of the above, we wish to clarify that the newly incorporated subsidiary i.e. Wockhardt Biologics Limited (‘WBL’), has been set up to carry out business in pharmaceutical industry.

Kindly take the same on record.

Thanking you,

for Wockhardt Limited

==> picture [114 x 43] intentionally omitted <==

Gajanand Sahu Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==